Generics Bulletin Podcasts

By Norstella

The Generics Bulletin Podcast takes you inside the trends and decisions driving the global generics and biosimilars industry. Created for industry professionals, episodes published bi-monthly feature ... more

· Business

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Generics Bulletin Podcasts:

How many episodes does Generics Bulletin Podcasts have?

The podcast currently has 5 episodes available.

Generics Bulletin Podcasts episodes:

August 04, 2026 Off-Patent, On Record: View Through The Journalist's Lens With Generics Bulletin's Dave Wallace
Generics Bulletin’s senior reporter Urtė Fultinavičiūtė launches a new interview podcast series “Off-Patent, On Record.” In the inaugural episode, Urtė is joined by Dave Wallace, executive editor at Generics Bulletin, who has been covering the off-patent drug industry as a journalist and editor for 16 years.
...more
25min
July 22, 2026The Next Era Of Oncology Biosimilars
Oncology biosimilars have already helped expand access to established biologic treatments while supporting more sustainable healthcare spending. As the market moves towards increasingly complex therapies, however, identifying viable opportunities will require more than monitoring patent expiries.
In this podcast, ICON experts Colin Farquharson and Martin Lachs, discuss how scientific innovation, evolving standards of care and changing market dynamics are influencing the next generation of oncology biosimilars.
This podcast explores:
How oncology biosimilars are moving from proof of concept towards broader adoption
The potential opportunities and challenges associated with antibody-drug conjugates and bispecific antibodies
Why patent expiry alone is not enough to determine the long-term viability of an asset
The factors influencing physician confidence, patient acceptance and market uptake
How real-world evidence can strengthen confidence in biosimilar safety and efficacy
The analytical, CMC, regulatory and market-planning capabilities sponsors should develop early
...more
18min
July 20, 2026 The Generics Bulletin Podcast: Summer Conferences
Generics Bulletin's editorial team discusses the recent Medicines for Europe legal and annual conferences, attended by executive editor Dave Wallace, as well as the Medicines UK conference attended by reporter Anabel Costa-Ferreira.
...more
23min
June 18, 2026 The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin
The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin
Description: Generics Bulletin senior reporter Urtė Fultinavičiūtė talks to Tahir Amin, co-founder and CEO of I-MAK, about the current intellectual property system that curtails off-patent drug competition and global health equity.
...more
29min
May 14, 2026 The Generics Bulletin Podcast: Biosimilars Conference Report And Big M&A Deals
Generics Bulletin's editorial team discusses the recent Medicines for Europe biosimilars conference, attended by deputy editor Dean Rudge; while editor Dave Wallace talks about the latest big deals in biosimilars and what is behind them.
...more
28min

FAQs about Generics Bulletin Podcasts:

How many episodes does Generics Bulletin Podcasts have?

The podcast currently has 5 episodes available.